ARTICLE | Company News
BioRelix, Merck deal
October 11, 2010 7:00 AM UTC
The companies partnered to discover and develop antibacterial drug candidates. BioRelix will screen compounds from Merck's library against proprietary bacterial RNA targets using the biotech's riboswi...